← SynDRA
LM22A-4
SynDRA canonical compound SYN1947336 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | NTRK2 |
|---|
| Mechanism of action | tropomyosin receptor kinase inhibitor |
|---|
Cross-references
Synonyms
- 1-N,3-N,5-N-tris(2-hydroxyethyl)benzene-1,3,5-tricarboxamide
- LM 22A4
- LM22a4
- 5GCL3P6AF5
- RefChem:924856
- DTXCID001527750
- N1,N3,N5-TRIS(2-HYDROXYETHYL)BENZENE-1,3,5-TRICARBOXAMIDE
- MFCD00382831
- LM 22A4, Potent TrkB agonist
- RGWJKANXFYJKHN-UHFFFAOYSA-N
- CBDivE_006973
- orb1299701
- SCHEMBL3321012
- LM22A-4 - Bio-X trade mark
- GLXC-03957
- N,N',N''-Tris(2-hydroxyethyl)-1,3,5-benzenetricarboxamide
- MBA98818
- EX-A10930
- AKOS024458250
- CS-6037
- NCGC00387179-04
- AS-16415
- BL300145
- DA-65027
- HY-100673
- T7568
- F468415
- SR-01000197745
- SR-01000197745-1
- 1,3,5-Benzenetricarboxamide, N,N',N''-tris(2-hydroxyethyl)-
- 1,3,5-Benzenetricarboxamide, N1,N3,N5-tris(2-hydroxyethyl)-
- N,N',N"-Tris (2-hydroxyethyl)-1,3,5-benzenetricarboxamide
- N1,N3,N5-Tris(2-hydroxyethyl)-1,3,5-benzenetricarboxamide
- N,N\',N\'\'-Tris(2-hydroxyethyl)-1,3,5-benzenetricarboxamide
- N,N',N''-Tris(beta-hydroxyethyl)trimesamide
Look up LM22A-4 in the interactive SynDRA portal →